STRIVE
LIVE

Serial Number

98090425

Owner

EMBECTA CORP.

Attorney

Stephen R. Baird

Filing Date

Jul 18, 2023

Add to watchlist:

No watchlists yet
View on USPTO

STRIVE Trademark

Serial Number: 98090425

STRIVE is a trademark filed by EMBECTA CORP. on July 18, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

EMBECTA CORP. (22 trademarks)

200 BULFINCH DRIVE
ANDOVER,, MA 01810

Entity Type: 03

Trademark Details

Filing Date

July 18, 2023

Registration Date

Not Registered

Goods & Services

Downloadable computer software for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Downloadable computer software for controlling and managing patient medical information; Downloadable computer software for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Downloadable computer software for acquiring, analyzing, transmitting and storing medical and physiological data; Downloadable computer software for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Downloadable computer software for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Downloadable computer software for use in the treatment and management of diabetes; Downloadable computer software for linking medical instruments and devices for use in the treatment and management of diabetes; Downloadable computer software for providing non-medical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Downloadable computer software for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Downloadable computer software for monitoring blood glucose in connection with blood glucose monitors; Downloadable computer software for controlling insulin delivery in connection with insulin pumps; Downloadable computer software for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps and glucose monitors; Downloadable computer software for obtaining, controlling, and managing patient medical information on wearable medical devices; Downloadable computer software for controlling and managing wearable insulin delivery devices; Downloadable computer software used to display, manage, and monitor diabetes management information; Downloadable software in the nature of a mobile application for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Downloadable software in the nature of a mobile application for controlling and managing patient medical information; Downloadable software in the nature of a mobile application for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Downloadable software in the nature of a mobile application for acquiring, analyzing, transmitting and storing medical and physiological data; Downloadable software in the nature of a mobile application for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Downloadable software in the nature of a mobile application for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Downloadable software in the nature of a mobile application for use in the treatment and management of diabetes; Downloadable software in the nature of a mobile application for linking medical instruments and devices for use in the treatment and management of diabetes; Downloadable software in the nature of a mobile application for providing non-medical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Downloadable software in the nature of a mobile application for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Downloadable software in the nature of a mobile application for monitoring blood glucose in connection with blood glucose monitors; Downloadable software in the nature of a mobile application for controlling insulin delivery in connection with insulin pumps; Downloadable software in the nature of a mobile application for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps and glucose monitors; Downloadable software in the nature of a mobile application for obtaining, controlling, and managing patient medical information on wearable medical devices; Downloadable software in the nature of a mobile application for controlling and managing wearable insulin delivery devices; Downloadable software in the nature of a mobile application used to display, manage, and monitor diabetes management information; Downloadable application programming interface (API) software; Wireless remote controllers for controlling and managing wearable insulin delivery devices

Providing temporary use of non-downloadable cloud-based software for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Providing temporary use of non-downloadable cloud-based software for controlling and managing patient medical information; Providing temporary use of non-downloadable cloud-based software for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Providing temporary use of non-downloadable cloud-based software for acquiring, analyzing, transmitting and storing medical and physiological data; Providing temporary use of non-downloadable cloud-based software for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Providing temporary use of non-downloadable cloud-based software for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Providing temporary use of non-downloadable cloud-based software for use in the treatment and management of diabetes; Providing temporary use of non-downloadable cloud-based software for linking medical instruments and devices for use in the treatment and management of diabetes; Providing temporary use of non-downloadable cloud-based software for providing non-medical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Providing temporary use of non-downloadable cloud-based software for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Providing temporary use of non-downloadable cloud-based software for monitoring blood glucose in connection with blood glucose monitors; Providing temporary use of non-downloadable cloud-based software for controlling insulin delivery in connection with insulin pumps; Providing temporary use of non-downloadable cloud-based software for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps and glucose monitors; Providing temporary use of non-downloadable cloud-based software for obtaining, controlling, and managing patient medical information on wearable medical devices; Providing temporary use of non-downloadable cloud-based software for controlling and managing wearable insulin delivery devices; Providing temporary use of non-downloadable cloud-based software used to display, manage, and monitor diabetes management information; Software as a Service (SAAS) services featuring software for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Software as a Service (SAAS) services featuring software for controlling and managing patient medical information; Software as a Service (SAAS) services featuring software for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Software as a Service (SAAS) services featuring software for acquiring, analyzing, transmitting and storing medical and physiological data; Software as a Service (SAAS) services featuring software for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Software as a Service (SAAS) services featuring software for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Software as a Service (SAAS) services featuring software for use in the treatment and management of diabetes; Software as a Service (SAAS) services featuring software for linking medical instruments and devices for use in the treatment and management of diabetes; Software as a Service (SAAS) services featuring software for providing non-medical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Software as a Service (SAAS) services featuring software for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Software as a Service (SAAS) services featuring software for monitoring blood glucose in connection with blood glucose monitors; Software as a Service (SAAS) services featuring software for controlling insulin delivery in connection with insulin pumps; Software as a Service (SAAS) services featuring software for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps and glucose monitors; Software as a Service (SAAS) services featuring software for obtaining, controlling, and managing patient medical information on wearable medical devices; Software as a Service (SAAS) services featuring software for controlling and managing wearable insulin delivery devices; Software as a Service (SAAS) services featuring software used to display, manage, and monitor diabetes management information; Application service provider (ASP) featuring software for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Application service provider (ASP) featuring software for controlling and managing patient medical information; Application service provider (ASP) featuring software for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Application service provider (ASP) featuring software for acquiring, analyzing, transmitting and storing medical and physiological data; Application service provider (ASP) featuring software for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Application service provider (ASP) featuring software for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Application service provider (ASP) featuring software for use in the treatment and management of diabetes; Application service provider (ASP) featuring software for linking medical instruments and devices for use in the treatment and management of diabetes; Application service provider (ASP) featuring software for providing non-medical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Application service provider (ASP) featuring software for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Application service provider (ASP) featuring software for monitoring blood glucose in connection with blood glucose monitors; Application service provider (ASP) featuring software for controlling insulin delivery in connection with insulin pumps; Application service provider (ASP) featuring software for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps and glucose monitors; Application service provider (ASP) featuring software for obtaining, controlling, and managing patient medical information on wearable medical devices; Application service provider (ASP) featuring software for controlling and managing wearable insulin delivery devices; Application service provider (ASP) featuring software for used to display, manage, and monitor diabetes management information; Application service provider featuring application programming interface (API) software; Consultation services relating to computer software; Providing on-line non-downloadable software featuring patient information management tools in the field of diabetes

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 22, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 22, 2025 GNSL
SUSPENSION LETTER WRITTEN
Sep 22, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 15, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 15, 2025 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 30, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 30, 2025 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 13, 2025 GNFN
FINAL REFUSAL E-MAILED
Mar 13, 2025 GNFR
FINAL REFUSAL WRITTEN
Mar 13, 2025 CNFR
DIVISIONAL PROCESSING COMPLETE
Feb 12, 2025 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 12, 2025 AITU
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 5, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 5, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 5, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 4, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 4, 2024 XELR
DIVISIONAL REQUEST RECEIVED
May 16, 2024 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
May 16, 2024 ERTD
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 5, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 5, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 5, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 1, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 16, 2023 NWOS
NEW APPLICATION ENTERED
Jul 21, 2023 NWAP